Kyntra Bio KYNB
NASDAQ KYNB
$3.20 -0.29 (-8.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Kyntra Bio (KYNB) Net of Acquisitions & Divestments (2020 - 2025)

Updated

Analysis

Kyntra Bio (KYNB) Net of Acquisitions & Divestments (2020 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Acquisitions (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -887.00 Mn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 17.15 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -10.59 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -630.00 Mn
5 Novartis Ag 310.90 Bn 284.14 Bn - 42.00 Mn
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -19.00 Mn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -
10 Kyntra Bio 12.57 Mn -395.37 Mn 1.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 6.41 Mn
Sep 30, 2020 -726,000.00
API Access

Kyntra Bio Net of Acquisitions & Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-of-acquisitions-and-divestments&ticker=KYNB&period=max&api_key=YOUR_API_KEY